| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MAZE over the last quarter tilts toward selling: insiders offloaded a net 227,492 shares worth roughly $6.1M. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MAZE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.47M | - | - | |
| CEO | 191.4K | $5.17M | -34,501 | |
| Pres | 144.5K | - | -16,141 | |
| CFO | 40.0K | - | - | |
| Other | 39.8K | $414.9K | -7,500 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Coloma Jason V | Chief Executive Officer | Sell | 34,501 | $27.02 | $932,259.56 | -14.3% | - | - | |
| Oct 1, 2026 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 16,141 | $26.93 | $434,743.31 | -100% | - | - | |
| Sep 29, 2026 | Dandekar Atul | Csbo | Sale+OE | 7,500 | $27.06 | $202,920.75 | -18.8% | - | - | |
| Sep 4, 2026 | Bernstein Harold64 | President, R&D &CMO | Sell | 9,705 | $26.22 | $254,501.98 | -100% | - | - | |
| Sep 3, 2026 | Dandekar Atul | Csbo | Sell | 6,434 | $26.24 | $168,810.96 | -16.6% | - | - | |
| Sep 3, 2026 | Coloma Jason V | Chief Executive Officer | Sell | 22,638 | $26.24 | $593,954.88 | -45.3% | - | - | |
| Sep 3, 2026 | Courtney Phillips | GC And Corp. Secretary | Sell | 3,993 | $26.24 | $104,765.54 | -36.3% | - | - | |
| Sep 3, 2026 | Bernstein Harold64 | President, R&D &CMO | Sell | 10,295 | $26.24 | $270,110.79 | -51.5% | - | - | |
| Sep 1, 2026 | Coloma Jason V | Chief Executive Officer | Sale+OE | 34,501 | $26.29 | $906,998.79 | -12.5% | - | - | |
| Sep 1, 2026 | Bernstein Harold64 | President, R&D &CMO | Sale+OE | 16,141 | $26.36 | $425,512.27 | -100% | - | - |